Claro Advisors’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-5,480
| Closed | -$517K | – | 379 |
|
|
2023
Q2 | $517K | Buy |
5,480
+31
| +0.6% | +$2.92K | 0.13% | 190 |
|
|
2023
Q1 | $451K | Buy |
5,449
+20
| +0.4% | +$1.66K | 0.13% | 193 |
|
|
2022
Q4 | $405K | Sell |
5,429
-1,011
| -16% | -$75.4K | 0.13% | 194 |
|
|
2022
Q3 | $612K | Hold |
6,440
| – | – | 0.24% | 105 |
|
|
2022
Q2 | $612K | Buy |
+6,440
| New | +$612K | 0.24% | 105 |
|
|
2022
Q1 | – | Sell |
-6,401
| Closed | -$829K | – | 283 |
|
|
2021
Q4 | $829K | Hold |
6,401
| – | – | 0.3% | 87 |
|
|
2021
Q3 | $725K | Buy |
6,401
+9
| +0.1% | +$1.02K | 0.3% | 84 |
|
|
2021
Q2 | $662K | Buy |
6,392
+20
| +0.3% | +$2.07K | 0.3% | 91 |
|
|
2021
Q1 | $533K | Buy |
6,372
+66
| +1% | +$5.52K | 0.27% | 106 |
|
|
2020
Q4 | $575K | Hold |
6,306
| – | – | 0.31% | 91 |
|
|
2020
Q3 | $503K | Hold |
6,306
| – | – | 0.32% | 91 |
|
|
2020
Q2 | $436K | Sell |
6,306
-30
| -0.5% | -$2.07K | 0.3% | 99 |
|
|
2020
Q1 | $398K | Buy |
6,336
+45
| +0.7% | +$2.83K | 0.37% | 84 |
|
|
2019
Q4 | $489K | Hold |
6,291
| – | – | 0.38% | 79 |
|
|
2019
Q3 | $461K | Hold |
6,291
| – | – | 0.41% | 71 |
|
|
2019
Q2 | $387K | Sell |
6,291
-45
| -0.7% | -$2.77K | 0.36% | 85 |
|
|
2019
Q1 | $404K | Buy |
6,336
+51
| +0.8% | +$3.25K | 0.4% | 76 |
|
|
2018
Q4 | $365K | Buy |
+6,285
| New | +$365K | 0.29% | 81 |
|